Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
about
Evolution of urological imagingCase report: PET/CT, a cautionary taleRegular review: Managing testicular cancerFusion imaging: a novel staging modality in testis cancer.Positron emission tomography in urologic oncology.Positron emission tomography in uro-oncology.PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.Advances in the management of testicular cancer.FDG-PET. A possible prognostic factor in head and neck cancer.The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.Nuclear medicine in urological cancers: what is new?αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study.Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.Imaging of testicular germ cell tumours.FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment.False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up.
P2860
Q27692114-2EA39ADC-DA1C-4E55-8043-34D40D524F4FQ33293417-8327503B-2ED3-42A9-8F86-FFC5CD33DD22Q33806081-3C29A539-F582-4CE1-A069-DF9A98459ACBQ34341986-AF2ECD1A-93A7-415F-BDEC-8657DCBAB8E8Q34849275-49D92560-ACAE-41A4-B249-6E3535346116Q35172954-A4D51557-0A86-428A-86A9-9AC1FA2FE33CQ35776939-949CF010-09F4-4A0B-9660-486678AB1C34Q35843721-2DB42F55-0C70-4A58-8420-49A9DE786817Q36644134-F2735C74-4596-4BB4-82D4-363CE338D8DAQ37725130-0D7D5E6B-03A9-484A-A371-6FBD99DD9BCDQ38268168-E5A21931-49F1-410D-B862-8ABA0DE772B3Q39649778-96C921BA-0382-4C48-ABE5-A1C07B6059FEQ40532423-62065EA6-7902-4414-84D3-8FC91BCA2A24Q40896429-C948CA00-4603-461C-B953-5693BC20680DQ42433649-A897B9E6-A9AE-46FC-8503-212B39AD0C98Q42750167-CEB268D6-2FD9-4F78-940E-FD57447C599BQ43993193-DD35820F-10EA-4420-BF11-72817F53952BQ44597356-72E36EC9-FE96-4FA2-A024-962C687A9D9A
P2860
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Fluorodeoxyglucose positron em ...... germ cell tumours at relapse.
@en
type
label
Fluorodeoxyglucose positron em ...... germ cell tumours at relapse.
@en
prefLabel
Fluorodeoxyglucose positron em ...... germ cell tumours at relapse.
@en
P2093
P2860
P356
P1476
Fluorodeoxyglucose positron em ...... germ cell tumours at relapse.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1389
P407
P577
2000-10-01T00:00:00Z
P5875
P6179
1017231079